Matthias Fueth
Basel, BS, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Comparable immunogenicity of new modality biotherapeutics delivered subcutaneously or intravenously in non-human primates.
Journal: Journal of immunotoxicology
Published: August 11, 2025
Are Ocular and Serum Half-Lives After Ranibizumab Intravitreal Injection Dependent on Dose?
Journal: Translational vision science & technology
Published: April 11, 2023
Targeting neuronal lysosomal dysfunction caused by β-glucocerebrosidase deficiency with an enzyme-based brain shuttle construct.
Journal: Nature communications
Published: April 01, 2022
Pharmacokinetics and Determination of Tumor Interstitial Distribution of a Therapeutic Monoclonal Antibody Using Large-Pore Microdialysis.
Journal: Journal of pharmaceutical sciences
Published: December 07, 2020
Ocular Half-Life of Intravitreal Biologics in Humans and Other Species: Meta-Analysis and Model-Based Prediction.
Journal: Molecular pharmaceutics
Published: December 27, 2019
Tissue Distribution of a Therapeutic Monoclonal Antibody Determined by Large Pore Microdialysis.
Journal: Journal of pharmaceutical sciences
Published: January 25, 2017
Development and validation of a HPLC-MS/MS method for the determination of phytolaccagenin in rat plasma and application to a pharmacokinetic study.
Journal: Journal of pharmaceutical and biomedical analysis
Published: September 29, 2014
Showing 1-10 of 10
Last Updated: 09/26/2026